Helicobacter pylori: The cancer link

Journal of the Royal Society of Medicine

Volumn 89, Issue 12, 1996, Pages 674-678

  O'Connor, F ^a   Buckley, M ^a   O'Morain, C ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CANCER MORTALITY; CANCER PREVENTION; CELL KINETICS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HISTOLOGY; HUMAN; MUTAGENICITY; PATHOGENICITY; PROGNOSIS; SHORT SURVEY; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH JUICE; STOMACH LYMPHOMA; STOMACH MUCOSA;

EID: 0030459797     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107689608901205     Document Type: Short Survey

References (53)

1. Parkin DM, Pisani P, Fearly J. Estimates of worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606
2. Rugge M, Sonego F, Panozzo M, et al. Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis. Cancer 1994;73:1127-33
3. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49
4. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-66
5. Correa P. Human gastric carcinogenesis: a multi-step and multifactorial process. Cancer Res 1992;52:6735-40
6. International Agency for Research on Cancer. Schistosomes, Liver Flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans, vol 61, Lyon: IARC, 1994
7. Perez-Perez GI, Taylor DN, Bodhidatta L, et al. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Disease 1990;161: 1237-41
8. EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1994;341:1359-62
9. The Gastrointestinal Physiology Working Group. Helicobacter pylori and gastritis in Peruvian patients: relationship to socioeconomic level, age and sex. Am J Gastroenterol 1990;85:819-23
10. Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin N Am 1993;22:89-104
11. Sipponen P, Seppälä K. Long-term consequences of H. pylori infection: time trends in H. pylori gastritis, gastric cancer and peptic ulcer disease. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: Basic Mechanisms to Clinical Cure. Boston: Kluwer 1994:372-80
12. Parsonnet DM, Friedman GT, Vandersteen DP, et al. Helicobacter pylori infection and risk for gastric carcinoma. N Engl J Med 1991;325:1127-31
13. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer; evidence of a prospective investigation. BMJ 1991;302:1302-5
14. Nomura A, Stemmerman GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6
15. Forman D, Webb P, Parsonnet J. Helicobacter pylori and gastric cancer. Lancet 1994;343:243-4
16. Tally NJ, Zinsmeister AR, Weaver A, Dimagno EP, Carpenter HA, Perez-Perez, GI, et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991;83:1734-9
17. Sipponen P, Kosunen TU, Valle J, Riihela M, Seppälä K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992;45:319-23
18. Hansson LE, Engstrand L, Nyren OL, et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993;105:1098-103
19. Kuipers EJ, Gracia-Casanova M, Pena AS, et al. Helicobacter pylori serology in patients with gastric carcinoma. Scand J Gastroenterol 1993;28:433-7
20. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273-5
21. Blaser MJ. Gastric Campylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterology 1987;93:371-83
22. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis-associated active antral gastritis: a prospective study of its prevalence and the effect on anti-bacterial and anti-ulcer treatment. Gastroenterology 1988;94:33-40
23. Dixon MF. Campylobacter pylori and chronic gastritis. In: Rathbone BJ, Heatley RV, eds. Campylobacter pylori and Gastroduodenal Disease. Oxford: Blackwell Scientific Publications, 1989:106-16
24. Craanen ME, Blok P, Dekker W, Fewerda J, Tytgat GNJ. Intestinal metaplasia and Helicobacter pylori: an endoscopic-bioptic study of the antrum. Gut 1992;33:16-20
25. Filipe MI. Histochemistry of intestinal mucins. In: Whitehead R, ed. Gastrointestinal and Oesophageal Pathology. Edinburgh: Churchill Livingstone, 1989: 71
26. Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991;32:1110-13
27. O'Connor F, Sweeney E, O'Morain C. Helicobacter pylori and subtypes of intestinal metaplasia in gastric antral mucosa. Irish J Med Sci 1995;74:225-6
28. Gilvarry JM, Leen E, Sweeney E, O'Morain C. The long term effect of Helicobacter pylori on gastric mucosa. Eur J Gastroenterol Hepatol 1994;6:43-5
29. Fujiwara Y, Kang J, Fujiwara K, Chang K, Tarnawksi A. Effects of non-steroidal anti-inflammatory drugs on cell proliferation in gastroduodenal mucosa. A review article. Eur J Gastroenterol Hepatol 1993;5:301-5
30. cdc2 in establishing the dependence of S phase on mitosis. Nature 1991;349:388-93
31. Hollywood DP, Lemoine NR. Growth factors, oncogenes and tumour suppressor genes. In: Hall P, Levison DA, Wright NA, eds. Assessment of Cell Proliferation in Clinical Practice. London: Springer-Verlag, 1992:27-41
32. Cahill RJ, Sant S, Beattie S, Hamilton H, O'Morain C. Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol 1994;6:1123-8
33. Cahill RJ, Sant S, Beattie S, Hamilton H, O'Morain C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 1995;40:1627-31
34. Cahill RJ, Kilgallen C, Beattie S, Hamilton H, O'Morain C. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut 1996;38:177-81
35. Freeman JT, Hafkesbring R. Comparative studies of ascorbic acid levels in gastric secretion and blood. Gastroenterology 1957;32:878-86
36. Hansson LE, Myren O, Bergstrom R, et al. Nutrients and gastric cancer risk. A population based control study in Sweden. Int J Cancer 1994;57:638-44
37. O'Connor HJ, Schorah CJ, Habilzedah N, Axon ATR, Cockel R. Vitamin C in the human stomach: relation to gastric pH, gastroduodenal disease and possible sources. Gut 1989;30:436-42
38. Bannerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, McColl KEL. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994;35:317-22
39. Correa P, Haenszel W, Cuello C, Tannenbaum SR, Archer M. A model for gastric cancer epidemiology. Lancet 1975;ii:58-60
40. Koningsberger JC, Marx JJM, Van Hattum J. Free radicals in gastroenterology. Scand J Gastroenterol 1988;23(suppl 154):30-40
41. Drake IM, Warland D, Carswell N, et al. Reactive oxygen species (ROS) activity and damage in Helicobacter pylori-associated gastritis (HPG)-effect of eradication therapy. Gut 1995;37(suppl 1):A155
42. Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration and gastric pathology. Lancet 1991;338:332-5
43. Crabtree JE, Farmery S, Lindley IJD, Peichl P, Tompkins DS. Cytotoxic strains of Helicobacter pylori induce IL-8 production form gastric epithelial cells (Abstr). Acta Gastroenterol Belg 1995; 56(suppl):48
44. Crabtree JE, Wyatt JI, Trejdosiewicz LK, et al. Interleukin 8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J Clin Pathol 1994;47:61-7
45. Wyatt JI, Rathbone BJ. Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 1989;23(suppl 154):44-9
46. Telford JL, Ghiara P, Dell'orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994;179:1653-8
47. Atherton JC, Cover TL, Ray KC, Peek RM, Perez-Perez, GI, Blaser MJ. Genotypic analysis of vacA and cagA in Helicobacter pylori isolates from the U.S., Thailand, Peru and China. Gut 1995;37(suppl 1): A275
48. Stolte M, Edti S. Lymphoid follicles in the antral mucosa: immune response to Campylobacter pylori. J Clin Pathol 1989;42:1269-71
49. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori injection in gastric lymphoma. N Engl J Med 1994;330:1267-71
50. Hussell T, Isaacson PG, Crabtree JE. The response of cells from low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1995;342:571-4
51. Wotherspoon AC, Doglioni C, Diss TC. Regression of primary low-grade-B-cell lymphoma of mucosa-associated lymphoid tissue after eradication of Helicobacter pylori. Lancet 1993;342:575-7
52. Bayerdörffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995;345:1591-4
53. Buckley M, Hamilton H, Beattie S, O'Morain C. A simplified reliable urea breath test. Gut 1995;37(suppl 1):A242